Today: 7 February 2026
Subscribe
Browse Category

Medical Technology News 5 December 2025 - 25 December 2025

Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms

Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms

Dec. 25, 2025 — Abbott Laboratories (NYSE: ABT) heads into the year-end stretch with a rare mix of near-term product momentum and headline-level risk management. Over the past several weeks—culminating in key December announcements—Abbott has (1) secured U.S. FDA approval for a next-generation atrial fibrillation ablation platform, (2) expanded its push into consumer biowearables, (3) navigated an FDA early alert tied to certain FreeStyle Libre sensors, and (4) doubled down on its diagnostics ambitions with a planned ~$23 billion enterprise-value acquisition of Exact Sciences. With U.S. markets closed for Christmas Day, investors are largely assessing Abbott based on its most
25 December 2025
·····
Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Date: December 21, 2025 (Sunday) Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the Christmas-shortened trading week with momentum—yet also with two developments investors will likely keep on the radar: a newly posted FDA Class 2 recall entry tied to a da Vinci 5 console component, and a recent FDA clearance that expands da Vinci SP into three high-volume general surgery procedures. ISRG last closed at $572.47 after rising 1.88% in the latest session, a move that outpaced the broader market on the day. MarketWatch+1 Below is the week-ahead playbook—what just happened, what Wall Street is forecasting, and what to watch
22 December 2025
·····
Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending the week in focus after a strong Friday close, fresh regulatory momentum for its single-port platform, and a new wave of Wall Street price-target updates heading into 2026. As of Dec. 20, 2025 (Saturday)—with U.S. markets closed—investors are digesting what’s next for the surgical robotics leader following a volatile December trading range and a busy stretch of headlines. Below is a detailed, publication-ready roundup of the current news, forecasts, and analyst commentary relevant as of 20.12.2025, plus what investors may be watching into early 2026. ISRG stock price today: where Intuitive Surgical shares
21 December 2025
····
4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) has become one of the most talked-about Australian small-cap healthcare names of late 2025—despite a bruising year for the broader sector. On 18 December 2025, fresh market coverage put the spotlight back on the stock’s extraordinary run and the commercial milestones behind it, as investors weighed a familiar question for fast-rising growth stories: is this the start of something bigger, or has the market moved too far, too fast? Livewire Markets The key news on 18 December 2025: a “small-cap sensation” goes mainstream The day’s most widely shared piece of coverage came from Livewire Markets, which framed 4DMedical
19 December 2025
·····
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Wednesday, December 17, 2025, as fresh Wall Street commentary and a new round of target-price updates reframe the conversation around the medtech leader’s 2026 setup—especially in fast-growing cardiac categories like electrophysiology (EP) and left atrial appendage closure (WATCHMAN). Investing.com+1 While Boston Scientific shares have been under pressure recently—down nearly 10% over the past month according to UBS—today’s headlines tilt toward a familiar theme: analysts see the pullback as creating a more attractive entry point into a multi-year growth story, even as valuation and policy risks remain key watch items.
17 December 2025
·····
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

December 15, 2025 — WORK Medical Technology Group LTD stock (Nasdaq: WOK) is back on traders’ radar as a hyper-volatile micro-cap with a story that reads like a corporate-actions speedrun: Nasdaq bid-price warnings, a 1-for-100 reverse stock split, rapid swings in market pricing, and fresh financing flexibility via an at-the-market (ATM) program. As of Dec. 15, 2025, market data platforms show WOK trading around $0.11, with a day range roughly $0.10–$0.15 and an eye-popping 52-week range of ~$0.10 to ~$624—a range that’s heavily distorted by the company’s reverse split and the way many platforms adjust historical prices. Investing.com+1 Below is
15 December 2025
·····
Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close)Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) Intuitive Surgical stock finished the week on the back foot—even as the robotic-surgery leader delivered a meaningful regulatory win. Shares of ISRG closed at $542.32 on Friday, Dec. 12, capping a five-session slide from $566.89 on Monday, Dec. 8 (a decline of roughly 4.3% across the week). Nasdaq The pullback came amid a busy headline flow that investors often take seriously in high-multiple medtech names: FDA clearance expanding da Vinci SP’s U.S. indications, a Citigroup downgrade, a Wells Fargo price-target increase, and fresh insider-selling paperwork. TradingView+3GlobeNewswire+3TipRanks+3 Below
13 December 2025
·····
Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical stock today: where things stand Intuitive Surgical Inc. (NASDAQ: ISRG), the robotics and minimally invasive surgery leader behind the da Vinci and Ion platforms, continues to trade near the top of its 52‑week range as of December 7, 2025. Specialist services that track Intuitive Surgical’s price history also show a strong rebound over the last three months, with shares approaching their late‑January 2025 high around $616. StockInvest+1 Year to date, ISRG is up high single digits, according to recent analyst commentary, after a volatile first half of 2025 and a strong move following third‑quarter earnings. Forbes+1 The very
7 December 2025
·····
Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Updated: December 7, 2025 Key Takeaways 1. Medtronic (MDT) Stock Snapshot on December 7, 2025 As of the latest completed trading session (Dec. 5, 2025), Medtronic’s NYSE‑listed shares closed at $101.36, with modest after‑hours trading around $101.31. StockAnalysis Key stats at a glance: Trading over the last week has been choppy as markets digest macro headlines and rotations within healthcare. On Dec. 1, MDT fell about 1.9% to $103.34, underperforming the S&P 500 and Dow. A day later, it slipped another 1.3% to $102.03, leaving it around 4% below its recent 52‑week high of $106.33. MarketWatch+1 Even so, post‑earnings commentary
7 December 2025
····
Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc (NYSE: MDT) stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of about 2.8%. MarketBeat+2StockAnalysis+2 In the first week of December, Medtronic has delivered a flurry of stock‑moving news: a new FDA clearance for its Hugo™ robotic-assisted surgery system, a U.S. launch of its next‑gen MiniMed™ 780G insulin pump with Abbott’s Instinct™ sensor, a fresh quarterly dividend declaration, and ongoing progress toward the spin‑off of its Diabetes business. At the same time,
6 December 2025
·····
Intuitive Surgical (ISRG) Stock in December 2025: Earnings Beat, Tariff Risks and New Robotic Rivals

Intuitive Surgical (ISRG) Stock in December 2025: Earnings Beat, Tariff Risks and New Robotic Rivals

Published: December 6, 2025 Intuitive Surgical, Inc. (NASDAQ: ISRG), the pioneer of robotic-assisted surgery and maker of the da Vinci and Ion systems, remains one of the most closely watched healthcare stocks as 2025 draws to a close. The company has delivered a powerful third-quarter earnings beat, continued double‑digit procedure growth and new AI-driven product upgrades—while at the same time warning about tariff-related margin pressure and facing fresh competition from Medtronic’s newly approved surgical robot. Intuitive+2Intuitive+2 For investors tracking Intuitive Surgical stock on Google News and Discover, here is a comprehensive look at the latest share price, earnings trends, forecasts
6 December 2025
····
Picard Medical (PMI) Stock Soars 82% After Artificial Heart Breakthrough: Is This Rally Sustainable?

Picard Medical (PMI) Stock Soars 82% After Artificial Heart Breakthrough: Is This Rally Sustainable?

Picard Medical, Inc. (NYSE American: PMI) just staged one of the most dramatic moves on Wall Street, with its stock surging more than 80% on December 4, 2025, after the company released new data on its next‑generation artificial heart. Investors are now asking a simple question: is this the start of a longer rerating, or just another spike in a highly volatile microcap? Picard Medical Stock at a Glance (as of December 4, 2025) On December 4, 2025, Picard Medical shares closed at $3.69, up $1.67 (+82.67%) from the prior close of $2.02, making PMI one of the top gainers
5 December 2025
·····
1 2 3 4 5 6

Stock Market Today

CrowdStrike stock jumps nearly 5% after Aramco pact — what investors watch next

CrowdStrike stock jumps nearly 5% after Aramco pact — what investors watch next

7 February 2026
CrowdStrike shares jumped 4.8% to $395.50 after the company announced a non-binding memorandum of understanding with Saudi Aramco. The move ended a seven-session losing streak for the stock, which remains about 30% below its 52-week high. Investors await more details on the Aramco talks and CrowdStrike’s March 3 earnings report. Trading volume topped 4.9 million shares, well above average.
Visa stock price edges up as Visa & Main rolls out — what’s next for NYSE:V

Visa stock price edges up as Visa & Main rolls out — what’s next for NYSE:V

7 February 2026
Visa shares closed up 0.74% at $331.58 Friday, holding steady after hours. The company launched “Visa & Main,” a $100 million working-capital facility for small businesses through Lendistry. Investors are watching program adoption and Visa’s Feb. 10 dividend record date. The S&P 500 rose 1.97% and American Express gained 1.28%.
Spotify stock rebounds after-hours as Bookshop.org move and new features tee up Q4 earnings

Spotify stock rebounds after-hours as Bookshop.org move and new features tee up Q4 earnings

7 February 2026
Spotify shares rose 2.4% in late after-hours trading Friday, closing at $422.61. The company this week announced U.S. and U.K. users can order physical books via Bookshop.org in-app, and introduced new audiobook and music features. Spotify raised Premium prices by $1 in select markets, sending shares down 4.5% Thursday. Investors await Q4 earnings on Feb. 10 for updates on revenue and new product impact.
Go toTop